All In Biotech

Free tool

FAERS Monitor: Inomax

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020845 or its brand name (Inomax, Nitric Oxide). Reports on generic versions are filed under their own applications.

Reports

2,910

Serious

2,770

95% of reports

Hospitalization

726

Death reported

1,302

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • product use issue377
  • death364
  • off label use342
  • drug ineffective329
  • product use in unapproved indication211
  • condition aggravated200
  • oxygen saturation decreased195
  • respiratory failure152
  • pulmonary hypertension151
  • hypotension138
  • hypoxia130
  • cardiac arrest111
  • drug ineffective for unapproved indication84
  • pulmonary haemorrhage83
  • therapy non-responder78

Reports by year received

View as table
YearReports
20047
200518
200643
200777
200840
200930
201040
201179
201239
201349
201455
201552
2016116
2017140
2018127
2019142
2020211
2021235
2022274
2023263
2024357
2025315
2026201

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,249 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
pulmonary haemorrhageSignal8377.562.66,127
pulmonary hypertensionSignal15152.845.17,568
hypoxiaSignal13026.822.63,194
oxygen saturation decreasedSignal19525.222.04,497
respiratory failureSignal15215.112.91,989
product use issueSignal37714.513.24,768
therapy non-responderSignal7812.610.1819
drug ineffective for unapproved indicationSignal8411.19.0761
cardiac arrestSignal1119.78.1863
product use in unapproved indicationSignal2116.25.4916
hypotensionSignal1385.04.2438
condition aggravatedSignal2004.84.2598
deathSignal3643.12.8522
off label useSignal3422.82.6418
drug ineffective3291.81.6125

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.